TeraWulf
WULF
Bitdeer Technologies
BTDR
Riot Platforms
RIOT
Bitfarms
BITF
Strategy
MSTR
US Stock MarketDetailed Quotes
DYN Dyne Therapeutics
- 13.610
- +0.440+3.34%
Close Feb 28 16:00 ET
- 13.610
- 0.0000.00%
Post 16:19 ET
1.54BMarket Cap-4.04P/E (TTM)
13.670High12.870Low1.76MVolume13.100Open13.170Pre Close23.70MTurnover2.17%Turnover RatioLossP/E (Static)113.12MShares47.45052wk High2.44P/B1.11BFloat Cap12.87052wk Low--Dividend TTM81.41MShs Float47.450Historical High--Div YieldTTM6.07%Amplitude4.300Historical Low13.448Avg Price1Lot Size
About Dyne Therapeutics Company
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Company Profile
SymbolDYN
Company NameDyne Therapeutics
Listing DateSep 17, 2020
Issue Price19.00
Founded2017
CEOMr. John G. Cox
MarketNASDAQ
Employees191
Fiscal Year Ends12-31
Address830 Winter Street
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-786-8230
Websitehttp://www.dyne-tx.com
Company Executives
- Name
- Position
- Salary
- John G. Cox
- Director, President and Chief Executive Officer
- --
- Dr. Oxana Beskrovnaya, PhD
- Chief Scientific Officer
- --
- Wildon Farwell, M.D.,M.P.H.
- Chief Medical Officer
- --
- Richard William Scalzo
- Senior Vice President, Head of Finance and Administration, Principal Financial and Accounting Officer
- --
- Jason P. Rhodes
- Chairman of the Board
- 283.17K
- Edward M. Hurwitz, J.D.
- Independent Director
- 250.17K
- Dirk Kersten
- Independent Director
- 262.67K
- Dr. Catherine Stehman-Breen, M.D.
- Independent Director
- 253.92K
- David Charles Lubner, C.P.A.,M.S.
- Independent Director
- 264.17K
- Dr. Carlo Incerti
- Independent Director
- 250.17K
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.